Annual financial report 2016 (PDF)
Vita 34 concludes purchase agreement for the entire acquisition of its competitor Seracell Pharma AG
Vita 34 AG
Welcome to the Vita 34 AG “Investor Relations” website.
On the following pages we offer you a comprehensive look into the Investor Relations activities of Vita 34 AG. We have tailored the transparent and extensive information on topics relative to the financial markets towards private shareholders, institutional investors, analysts and all for whom the commercial development of Vita 34 AG is of interest.
We would be more than happy to answer your questions directed at email@example.com.